Pharma 6 Flashcards

(28 cards)

1
Q

GLP-1 Receptor Agonists include

A

Semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism of action of semaglutide

A

Analogues of GLP-1; activate GLP-1 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Effect of semaglutide

A

Multi-organ Effects:
o Pancreas: Glucose-dependent Insulin secretion. Suppresses
Glucagon.
o Stomach: Slows gastric emptying (Feel full faster).
o Brain: Acts on hypothalamus to reduce appetite (Weight loss).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dosing fof exanatide

A

BID/ weekly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dosing of semaglutide

A

Injection once a week or daily oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GLP-1 Receptor Agonist with the highest efficacy for weight & A1c CV benefit

A

Semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cause and managment of GIT side effects with GLP-1 Receptor Agonists

A

Due to delayed gastric emptying
o Management: Titrate slowly. Stop eating when ful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Contraindications of GLP-1 Receptor Agonists

A

▪ patients with personal or family history of medullary thyroid
cancer.
▪ Chronic pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DPP-4 inhibitors include

A

Sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of action of sitaglipitin

A

Inhibit DPP-4 enzyme → ↑ endogenous GLP-1.→ increase insulin
and decrease glucagon, suppressing hepatic glucose output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pros of sitaglipitin

A

Oral, weight neutral, very well tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cons of sitaglipitin

A

Modest efficacy, no major CV benefit (neutral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SGLT2 Inhibitors include

A

Dapagliflozin , Empagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of action of SGLT2 inhibitors

A

Inhibit sodium–glucose co-transporter 2 in proximal renal tubule
▪ Result: Blocks glucose reabsorption→ increased glucosuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Benefits of SGLT2 inhibtors

A

Weight loss and blood pressure reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Administration of SGLT2 inhibitors

A

Given once daily in the morning before the first meal of the day

17
Q

An SGLT2 inhibitor approved to reduce CVS events in patients with type 2 dm

A

Empagliflozin

18
Q

Adverse effects of SGLT2 inhibitors

A

▪ Genital/urinary tract infections
▪ Dehydration
▪ Hypotension
▪ Euglycemic DKA: DKA with normal sugar (< 250). Rare

19
Q

Amyline analogues include

20
Q

Mechanism of action of pramlintide

A

Synthetic analog of Amylin (co-secreted with insulin)
▪ Action: Slows gastric emptying, suppresses glucagon.

21
Q

Theraputic use of pramlintide

A

Adjunct in T1 and T2 DM (Injectable)

22
Q

Side effects of pramlintide

A

Nausea,
Increased hypoglycemia risk with insulin

23
Q

Side effects of sitagliptin

A

▪ Nasopharyngitis (most common).
▪ Acute pancreatitis
▪ Disabling joint pain(arthropathy).
▪ increase the risk of heart failure hospitalizations

24
Q

ASCVD High Risk

A

GLP-1 RA or SGLT-2i (with proven benefit)

25
Heart Failure
SGLT-2i (Preferred)
26
CKD (Albuminuria)
SGLT-2i (Preferred) or GLP-1 RA
27
Obesity
GLP-1 RA (Semaglutide) or SGLT-2i
28
Cost Issue
Sulfonylurea or TZD